Viewing Study NCT06203457


Ignite Creation Date: 2025-12-24 @ 6:40 PM
Ignite Modification Date: 2025-12-29 @ 5:53 AM
Study NCT ID: NCT06203457
Status: COMPLETED
Last Update Posted: 2025-04-03
First Post: 2023-11-16
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Open-Label Extension Study to Evaluate the Safety of Efgartigimod in Adult Patients With Primary Sjögren's Syndrome
Sponsor: argenx
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module